Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients
- PMID: 25272005
- PMCID: PMC4182798
- DOI: 10.1371/journal.pone.0109012
Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients
Abstract
One of the most common cancers worldwide is oral squamous cell carcinoma (OSCC), which is associated with a significant death rate and has been linked to several risk factors. Notably, failure to detect these neoplasms at an early stage represents a fundamental barrier to improving the survival and quality of life of OSCC patients. In the present study, serum samples from OSCC patients (n = 25) and healthy controls (n = 25) were subjected to two-dimensional gel electrophoresis (2-DE) and silver staining in order to identify biomarkers that might allow early diagnosis. In this regard, 2-DE spots corresponding to various up- and down-regulated proteins were sequenced via high-resolution MALDI-TOF mass spectrometry and analyzed using the MASCOT database. We identified the following differentially expressed host-specific proteins within sera from OSCC patients: leucine-rich α2-glycoprotein (LRG), alpha-1-B-glycoprotein (ABG), clusterin (CLU), PRO2044, haptoglobin (HAP), complement C3c (C3), proapolipoprotein A1 (proapo-A1), and retinol-binding protein 4 precursor (RBP4). Moreover, five non-host factors were detected, including bacterial antigens from Acinetobacter lwoffii, Burkholderia multivorans, Myxococcus xanthus, Laribacter hongkongensis, and Streptococcus salivarius. Subsequently, we analyzed the immunogenicity of these proteins using pooled sera from OSCC patients. In this regard, five of these candidate biomarkers were found to be immunoreactive: CLU, HAP, C3, proapo-A1 and RBP4. Taken together, our immunoproteomics approach has identified various serum biomarkers that could facilitate the development of early diagnostic tools for OSCC.
Conflict of interest statement
Figures



Similar articles
-
Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review.Biomedicines. 2023 May 16;11(5):1458. doi: 10.3390/biomedicines11051458. Biomedicines. 2023. PMID: 37239129 Free PMC article. Review.
-
Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.Glycoconj J. 2021 Feb;38(1):1-11. doi: 10.1007/s10719-021-09973-z. Epub 2021 Feb 6. Glycoconj J. 2021. PMID: 33547992
-
Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1535-44. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973038 Free PMC article.
-
Comparative sera proteomics analysis of differentially expressed proteins in oral squamous cell carcinoma.PeerJ. 2021 Jun 10;9:e11548. doi: 10.7717/peerj.11548. eCollection 2021. PeerJ. 2021. PMID: 34178453 Free PMC article.
-
Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.J Immunol Res. 2018 Nov 12;2018:1061780. doi: 10.1155/2018/1061780. eCollection 2018. J Immunol Res. 2018. PMID: 30539028 Free PMC article. Review.
Cited by
-
Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.BMC Cancer. 2018 Jan 31;18(1):117. doi: 10.1186/s12885-018-4011-8. BMC Cancer. 2018. PMID: 29386009 Free PMC article.
-
Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.Mol Genet Metab. 2017 Jan-Feb;120(1-2):101-110. doi: 10.1016/j.ymgme.2016.10.001. Epub 2016 Oct 11. Mol Genet Metab. 2017. PMID: 27742266 Free PMC article.
-
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients.Sci Rep. 2019 Feb 8;9(1):1691. doi: 10.1038/s41598-018-38031-2. Sci Rep. 2019. PMID: 30737418 Free PMC article.
-
Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review.Biomedicines. 2023 May 16;11(5):1458. doi: 10.3390/biomedicines11051458. Biomedicines. 2023. PMID: 37239129 Free PMC article. Review.
-
Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic Procedures.Molecules. 2019 Feb 22;24(4):794. doi: 10.3390/molecules24040794. Molecules. 2019. PMID: 30813269 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108. - PubMed
-
- Jemal A, Bray F (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90. - PubMed
-
- Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195–215. - PubMed
-
- Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091–2098. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous